For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | ||
|---|---|---|---|---|
| Research and development | 5,039 | 8,400* | ||
| Sales and marketing | 343 | 543* | ||
| General and administrative | 2,120 | 3,799* | ||
| Gain on lease modification, net | - | 235* | ||
| Total operating expenses | 7,502 | 12,506 | ||
| Loss from operations | -7,502 | -12,506* | ||
| Loss on disposal of leasehold improvements | - | -479* | ||
| Change in fair value of warrant liabilities | - | -197* | ||
| Gain on sale of equipment | 133 | - | ||
| Interest and other income, net | 40 | 243* | ||
| Total other income, net | 173 | -39* | ||
| Net loss | -7,329 | -12,545* | ||
| Net unrealized (loss) income on investments | - | -11 | ||
| Net unrealized loss on investments | -6 | - | ||
| Other comprehensive loss | -6 | -11* | ||
| Comprehensive net loss | -7,335 | -12,557 | ||
| Basic EPS | -1.03 | -2.048 | ||
| Diluted EPS | -1.03 | -2.048 | ||
| Basic Average Shares | 7,120,298 | 6,130,652 | ||
| Diluted Average Shares | 7,120,298 | 6,130,652 | ||
Vicarious Surgical Inc. (RBOTW)
Vicarious Surgical Inc. (RBOTW)